Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.567, 2008-01, pp. : 2-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rivaroxaban cost effective in various settings
Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. :
Access to resources
Recommend
CRT a cost-effective option in Scandinavian settings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 568, 2008-01 ,pp. :
TB screening cost effective in two different settings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 657, 2012-01 ,pp. :
Cost effective treatment options for AS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 537, 2007-01 ,pp. :
Alemtuzumab effective in MS, but at a cost
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :